$15.1101
0.0401[0.27%]
At close: May 10
$15.1101
0[0.00%]
After Hours: 7:22PM EDT
Merrimack Pharmaceuticals
(NASDAQ:MACK)Latest News for Merrimack Pharmaceuticals Stock (NASDAQ:MACK)
Merrimack Pharmaceuticals Stock (NASDAQ: MACK)
Categories: All
Friday, May 10, 2024
Tuesday, April 30, 2024
Wednesday, March 27, 2024
Thursday, March 07, 2024
Tuesday, February 13, 2024
- Ipsen's Onivyde Regimen, A Potential New Standard-Of-Care First-Line Therapy In Metastatic Pancreatic Adenocarcinoma, Approved By FDABenzinga Newsdesk - Feb 13, 2024, 4:50PM
- Merrimack Management Estimates That The Aggregate Amount Of The Liquidating Dividend Payable To Stockholders Will Be In The Range Of Between Approximately $14.65 And $15.35 Per ShareBenzinga Newsdesk - Feb 13, 2024, 4:25PM
- Merrimack Says Ipsen's FDA Approval Of Onivyde sNDA Triggers $225M Payment From Ipsen to MerrimackBenzinga Newsdesk - Feb 13, 2024, 4:24PM
- BZ NOTE: Merrimack Pharmaceuticals, As Part Of Its Agreement With Ipsen For The Sale Of Its Oncology Assets Including ONIVYDE, Is Eligible To Receive Additional Payments With The Possibility Of Up To $450M Contingent Upon The Approval Of Potential New Indications For ONIVYDE In The U.S.Benzinga Newsdesk - Feb 13, 2024, 1:31PM
- FDA Approves Irinotecan Liposome For First-line Treatment Of Metastatic Pancreatic AdenocarcinomaBenzinga Newsdesk - Feb 13, 2024, 1:19PM
Tuesday, December 12, 2023
Thursday, November 02, 2023
Thursday, August 03, 2023
Thursday, May 04, 2023
Wednesday, March 15, 2023
Thursday, March 09, 2023
Wednesday, February 01, 2023
Wednesday, January 18, 2023
Tuesday, January 10, 2023
Wednesday, January 04, 2023
Thursday, November 10, 2022
Wednesday, November 09, 2022
- Nasdaq Drops 200 Points; Meta Platforms Shares JumpLisa Levin - Nov 9, 2022, 2:24PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Nov 9, 2022, 1:44PM
- Ten Stocks Trending on Discord for Wednesday November 9, 2022: TSLA, META, MACK, NRBO, AFRM, KALA, DIS, CLVS, UPST, COINCharles Gross - Nov 9, 2022, 1:22PM
- Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 9, 2022, 12:33PM
- Crude Oil Down Over 2%; Outset Medical Shares Spike HigherLisa Levin - Nov 9, 2022, 12:19PM
- Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On WednesdayLisa Levin - Nov 9, 2022, 10:54AM
- US Stocks Open Lower; Dow Drops 250 PointsLisa Levin - Nov 9, 2022, 10:10AM
- Why Merrimack Shares Are Surging Over 200% Today?Vandana Singh - Nov 9, 2022, 9:04AM
- Merrimack Pharmaceuticals shares are trading higher after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $450 million in milestone payments for the pancreatic cancer treatment.Benzinga Newsdesk - Nov 9, 2022, 8:50AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Nov 9, 2022, 7:16AM
- Shares of Merrimack Pharmaceuticals Rise 100% Preamarket Following Ipsen Report that Onivyde Met Primary and Key Secondary Endpoint; Merrimack is Eligible for Up to $450M Milestone Payment for the Pancreatic Cancer TreatmentCharles Gross - Nov 9, 2022, 5:25AM
- Ipsen Announced Onivyde Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma; Trial Met its Primary Endpoint and Key Secondary EndpointCharles Gross - Nov 9, 2022, 5:21AM
Thursday, November 03, 2022
Tuesday, October 18, 2022
Monday, October 10, 2022
Friday, October 07, 2022
Wednesday, October 05, 2022
Thursday, August 04, 2022
Wednesday, August 03, 2022
- Recap Of Wednesday's Biotech Catalysts - End Of the Day SummaryRagothaman Srinivasan - Aug 3, 2022, 6:24PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Aug 3, 2022, 2:08PM
- Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival MeasureVandana Singh - Aug 3, 2022, 11:49AM